Helen E. McGrath

A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days

Charlotte Benson, Jeff White, Johann S. de Bono et al. · British Journal of Cancer · 2006 · 257 citations · Full text

Lomeguatrib, a Potent Inhibitor of <i>O</i>6-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic Trial and Evaluation in Combination with Temozolomide in Patients with Advanced Solid Tumors

Malcolm Ranson, Mark R. Middleton, John Bridgewater et al. · Clinical Cancer Research · 2006 · 142 citations · Full text

Biologic significance of constitutive and subliminal growth factor production by bone marrow stroma

EL Kittler, Helen E. McGrath, D Temeles et al. · Blood · 1992 · 142 citations · Full text

Recombinant murine granulocyte macrophage colony-stimulating factor has megakaryocyte colony-stimulating activity and augments megakaryocyte colony stimulation by interleukin 3.

B E Robinson, Helen E. McGrath, P. J. Quesenberry · Journal of Clinical Investigation · 1987 · 134 citations · Full text

Colony-stimulating Activity, Immunology, Immune Regulation +19

Salt Sensitivity of Blood Pressure Is Associated With Polymorphisms in the Sodium-Bicarbonate Cotransporter

Robert M. Carey, Cynthia D. Schoeffel, John J Gildea et al. · Hypertension · 2012 · 93 citations · Full text

Hypertension, Genetics, Genetic Epidemiology +18